Mergers & Acquisitions Mergers & Acquisitions

US Anesthesia Partners to face FTC suit over rollup; investor Welsh Carson's case dismissed

By Khushita Vasant and Ben Brody
  • 14 May 2024 02:23
  • 14 May 2024 03:25
US Anesthesia Partners will face allegations from the US Federal Trade Commission that it illegally monopolized anesthesiology services in Texas through an anticompetitive rollup, even as private equity firm Welsh Carson, which had generated some of the acquisition strategy as part of its investment in USAP, escaped the lawsuit.

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Khushita Vasant

Chief Antitrust Correspondent, US

Khushita covers US antitrust enforcement and litigation for MLex. A former Brussels hand, she wrote about about antitrust & mergers for the Policy and Regulatory Report (PaRR), she has covered the EU's actions against Google, Apple, Facebook and Amazon to name a few. Khushita specialises in tech and patent policy coverage which featured in the Concurrences Antitrust Writing Awards. Previously as a financial journalist for The Wall Street Journal and Dow Jones Newswires, she wrote about monetary policy and the bond and currency markets. Khushita studied journalism at Mumbai University, and received an Erasmus Mundus scholarship for a masters from universities in Germany and Austria.

Discover MLex

Stay on top of global regulatory developments

Latest News